© Copyright 2016 The KINDReD ASSOCIATION. All rights reserved.
HOME MEMBERS NEGLECTED PARASITIC DISEASES DRUG DEVELOPMENT PIPELINE NEWS & PUBLICATIONS JOIN US CONTACT
Made in France

PIPELINE

Currently, The KINDReD Association owns two promising therapeutic molecules validated by preclinical studies.

Candicidin, a promising therapeutic molecule designed to fight

against cutaneous Leishmaniasis.

More information available soon.

K777,  a promising therapeutic molecule designed to defeat Chagas

disease.

More information available soon.
Together, we will win against  neglected infectious diseases.
PIPELINE
© Copyright 2016 The KINDReD ASSOCIATION. All rights reserved.
NAVIGATION MENU
Made in France

PIPELINE

Currently, The KINDReD Association owns two promising therapeutic molecules validated by preclinical studies.

Candicidin, a

promising therapeutic

molecule designed to

fight against

cutaneous

Leishmaniasis.

More information available soon.

K777,  a promising

therapeutic molecule

designed to defeat

Chagas disease.

More information available soon.
Together, we will win against  neglected infectious diseases.